OPCH

SEC source: 0001127602-19-026643 · form4.xml · derivative · entry 4

Booker Harriet · CIK 0001723978 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.0001 Par Value · 40,419 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F1 · date: The remaining unvested 40,419 Restricted Stock Units (RSUs) vested on August 6, 2019, due to the occurrence of a change of control (as defined in Ms. Booker's grant agreement); however, as provided in the grant agreement, the Company deferred settlement of the 40,419 RSUs until August 12, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F5 · derivative.exercise_date: This RSU award consisted of 60,629 RSUs, vesting in three equal installments on the first through third anniversaries of the date of grant (4/11/18). The first installment vested on 4/11/2019, and the second two installments vested upon August 6, 2019, due to the occurrence of a change of control (as defined in Ms. Booker's grant agreement).

F5 · derivative.expiration_date: This RSU award consisted of 60,629 RSUs, vesting in three equal installments on the first through third anniversaries of the date of grant (4/11/18). The first installment vested on 4/11/2019, and the second two installments vested upon August 6, 2019, due to the occurrence of a change of control (as defined in Ms. Booker's grant agreement).

SEC source: 0001127602-19-026643 · form4.xml · nonDerivative · entry 3

Booker Harriet · CIK 0001723978 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,349

F4 · price: This transaction represents shares withheld by the Company for tax withholding on Ms. Booker's settlement of the RSU awards described in this Form 4 that were settled on August 12, 2019.

SEC source: 0001127602-19-026643 · form4.xml · nonDerivative · entry 2

Booker Harriet · CIK 0001723978 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,966

F3 · date: 217,057 RSUs that were based on performance criteria vested on August 6, 2019, due to the occurrence of a change of control (as defined in Ms. Booker's grant agreement); however, as provided in the grant agreement, the Company deferred settlement of the 217,057 RSUs until August 12, 2019.

SEC source: 0001127602-19-026643 · form4.xml · nonDerivative · entry 1

Booker Harriet · CIK 0001723978 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,909

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: The remaining unvested 40,419 Restricted Stock Units (RSUs) vested on August 6, 2019, due to the occurrence of a change of control (as defined in Ms. Booker's grant agreement); however, as provided in the grant agreement, the Company deferred settlement of the 40,419 RSUs until August 12, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001127602-19-027524 · form4.xml · nonDerivative · entry 3

DENNESS RICHARD · CIK 0001746409 · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,856

F4 · price: This transaction represents shares withheld by the Company for tax withholding on Mr. Denness' settlement of the two RSU awards described in this Form 4 as well as the settlement of the RSU award granted on March 13, 2019, that settled on August 1, 2019 (reported on a Form 4 filed on August 20, 2019).

SEC source: 0001127602-19-027524 · form4.xml · nonDerivative · entry 2

DENNESS RICHARD · CIK 0001746409 · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,281

F3 · date: The 42,614 shares of Common Stock reported on this line represent the vesting of 42,614 RSUs granted on August 1, 2018, the vesting of which were based on satisfaction of EBITDA-based performance metrics. Such performance metrics were deemed satisfied in full based on the consummation of a change in control as defined in the grant agreement on August 6, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001437749-23-024319 · rdgdoc.xml · derivative · entry 1

GOLDING DAVID W · CIK 0001286630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,905 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") was the economic equivalent of one share of BioScrip, Inc. ("BioScrip") common stock. Upon vesting, the Cash-Settled RSUs entitled the reporting person to the "Fair Market Value" of one share of BioScrip's common stock on the vesting date, which was $2.67.

F2 · derivative.exercise_date: Each Cash-Settled RSU vested upon the completion of the merger of HC Group Holdings I, LLC and HC Group Holdings II, Inc. with and into BioScrip, which was then rebranded as Option Care Health, Inc.

F2 · derivative.expiration_date: Each Cash-Settled RSU vested upon the completion of the merger of HC Group Holdings I, LLC and HC Group Holdings II, Inc. with and into BioScrip, which was then rebranded as Option Care Health, Inc.

SEC source: 0001437749-23-024320 · rdgdoc.xml · derivative · entry 2

Pate R Carter · CIK 0001641406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,363 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") was the economic equivalent of one share of BioScrip, Inc. ("BioScrip") common stock. Upon vesting, the Cash-Settled RSUs entitled the reporting person to the "Fair Market Value" of one share of BioScrip's common stock on the vesting date, which was $2.67.

F2 · derivative.exercise_date: Each Cash-Settled RSU vested upon the completion of the merger of HC Group Holdings I, LLC and HC Group Holdings II, Inc. with and into BioScrip, which was then rebranded as Option Care Health, Inc.

F2 · derivative.expiration_date: Each Cash-Settled RSU vested upon the completion of the merger of HC Group Holdings I, LLC and HC Group Holdings II, Inc. with and into BioScrip, which was then rebranded as Option Care Health, Inc.

SEC source: 0001127602-19-027524 · form4.xml · derivative · entry 4

DENNESS RICHARD · CIK 0001746409 · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,878

Underlying: Common Stock, $.0001 Par Value · 18,940 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F1 · date: 18,940 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (August 1, 2018).

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F5 · derivative.exercise_date: The remaining 37,878 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (8/1/2018).

F5 · derivative.expiration_date: The remaining 37,878 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (8/1/2018).

SEC source: 0001127602-19-027524 · form4.xml · nonDerivative · entry 1

DENNESS RICHARD · CIK 0001746409 · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,667

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: 18,940 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (August 1, 2018).

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0000899243-19-019439 · doc4.xml · derivative · entry 3

Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner

Shackelton Christopher S · CIK 0001430708 · Director · 10% owner

Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner

COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner

Coliseum Capital Partners II, L.P. · CIK 0001567187 · Director · 10% owner

Gray Adam · CIK 0001454123 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 0

Underlying: Common Stock · 43,726 shares

Expires 2019-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock (the "Common Stock"). Each share of phantom stock is entitled to a cash payment equal to the fair market value of one share of the Common Stock as of the payment date based on the closing market price of the Common Stock on such date. The cash settlement of the phantom stock is reported for purposes of Form 4 as the disposition of the phantom stock and a simultaneous acquisition and disposition of the underlying Common Stock.

F1 · price: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock (the "Common Stock"). Each share of phantom stock is entitled to a cash payment equal to the fair market value of one share of the Common Stock as of the payment date based on the closing market price of the Common Stock on such date. The cash settlement of the phantom stock is reported for purposes of Form 4 as the disposition of the phantom stock and a simultaneous acquisition and disposition of the underlying Common Stock.

F2 · price: The fair market value of the shares of phantom stock is equal to the closing price of the Issuer's Common Stock on the business day immediately preceding the 2019 annual meeting of the Issuer's stockholders. The Issuer filed a definitive proxy statement on April 30, 2019 establishing June 11, 2019 as the date of the Issuer's 2019 annual meeting of stockholders. Therefore, the fair market value of the shares of phantom stock is equal to $2.19, which was the closing price of the Issuer's Common Stock on June 10, 2019.

F3 · ownership.nature: The phantom stock was received by Christopher Shackelton ("Shackelton") in connection with his service as a member of the board of directors of the Issuer. Shackelton has agreed that all equity awards he receives for serving as a director of the Issuer shall be issued to Coliseum Capital Partners, L.P. ("CCP").

F5 · ownership.nature: Shackelton and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC, and may be deemed to have an indirect pecuniary interest in the shares held by the Funds and the Separate Account due to CCM's right to receive performance-related fees from the Separate Account and CC's right to receive performance-related fees from the Funds. Each of Shackelton, Gray, CCP, CCP2, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.

F6 · ownership.nature: Following the transactions reported herein, CCP, CCP2 and the Separate Account directly owned 1,167,330; 260,942; and 460,719 shares of Common Stock, respectively.

SEC source: 0000899243-19-019439 · doc4.xml · nonDerivative · entry 2

Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner

Shackelton Christopher S · CIK 0001430708 · Director · 10% owner

Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner

COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner

Coliseum Capital Partners II, L.P. · CIK 0001567187 · Director · 10% owner

Gray Adam · CIK 0001454123 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,888,991

F2 · price: The fair market value of the shares of phantom stock is equal to the closing price of the Issuer's Common Stock on the business day immediately preceding the 2019 annual meeting of the Issuer's stockholders. The Issuer filed a definitive proxy statement on April 30, 2019 establishing June 11, 2019 as the date of the Issuer's 2019 annual meeting of stockholders. Therefore, the fair market value of the shares of phantom stock is equal to $2.19, which was the closing price of the Issuer's Common Stock on June 10, 2019.

F4 · ownership.nature: The Common Stock is held directly by (a) CCP, an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser, (b) Coliseum Capital Partners II, L.P. ("CCP2" and, together with CCP, the "Funds"), an investment limited partnership of which CC is general partner and for which CCM serves as investment adviser, and (c) a separate account investment advisory client of CCM (the "Separate Account").

F5 · ownership.nature: Shackelton and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC, and may be deemed to have an indirect pecuniary interest in the shares held by the Funds and the Separate Account due to CCM's right to receive performance-related fees from the Separate Account and CC's right to receive performance-related fees from the Funds. Each of Shackelton, Gray, CCP, CCP2, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.

SEC source: 0000899243-19-019439 · doc4.xml · nonDerivative · entry 1

Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner

Shackelton Christopher S · CIK 0001430708 · Director · 10% owner

Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner

COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner

Coliseum Capital Partners II, L.P. · CIK 0001567187 · Director · 10% owner

Gray Adam · CIK 0001454123 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 1,932,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock (the "Common Stock"). Each share of phantom stock is entitled to a cash payment equal to the fair market value of one share of the Common Stock as of the payment date based on the closing market price of the Common Stock on such date. The cash settlement of the phantom stock is reported for purposes of Form 4 as the disposition of the phantom stock and a simultaneous acquisition and disposition of the underlying Common Stock.

F4 · ownership.nature: The Common Stock is held directly by (a) CCP, an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser, (b) Coliseum Capital Partners II, L.P. ("CCP2" and, together with CCP, the "Funds"), an investment limited partnership of which CC is general partner and for which CCM serves as investment adviser, and (c) a separate account investment advisory client of CCM (the "Separate Account").

F5 · ownership.nature: Shackelton and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC, and may be deemed to have an indirect pecuniary interest in the shares held by the Funds and the Separate Account due to CCM's right to receive performance-related fees from the Separate Account and CC's right to receive performance-related fees from the Funds. Each of Shackelton, Gray, CCP, CCP2, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.

SEC source: 0000899243-19-015635 · doc4.xml · derivative · entry 1

Coliseum Capital Management, LLC · CIK 0001409751 · Director · 10% owner

Shackelton Christopher S · CIK 0001430708 · Director · 10% owner

Coliseum Capital, LLC · CIK 0001409585 · Director · 10% owner

COLISEUM CAPITAL PARTNERS, L.P. · CIK 0001356974 · Director · 10% owner

Coliseum Capital Partners II, L.P. · CIK 0001567187 · Director · 10% owner

Gray Adam · CIK 0001454123 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 18,905

Underlying: Common Stock · 18,905 shares

Expires not disclosed

F1 · derivative.exercise_price: Each cash-settled restricted stock unit ("Cash-Settled RSU") is the economic equivalent of one share of the Issuer's common stock (the "Common Stock"). Each vested Cash-Settled RSU is entitled to a cash payment equal to the fair market value of one share of the Common Stock as of the Vesting Date (as defined below) based on the closing market price of the Common Stock on such date, or if no such closing market price is available on such date, for the immediately preceding business day.

F3 · price: The Cash-Settled RSUs were granted on June 3, 2019 under the Issuer's 2018 Equity Incentive Plan. These securities were received by Shackelton in connection with his service as a member of the board of directors of the Issuer. Shackelton has agreed that all equity awards he receives for serving as a director of the Issuer shall be issued to Coliseum Capital Partners, L.P. ("CCP"). CCP is an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser.

F2 · derivative.exercise_date: The Cash-Settled RSUs will vest upon the earlier of (i) the consummation of a change of control or (ii) the date that is one day prior to the date of the Issuer's 2020 Annual Meeting of Stockholders (the earlier to occur of (i) or (ii), the "Vesting Date"), provided that Christopher Shackelton ("Shackelton") remains in the continuous service as a member of the board of directors of the Issuer at all times following the grant date (June 3, 2019) and prior to the Vesting Date.

F2 · derivative.expiration_date: The Cash-Settled RSUs will vest upon the earlier of (i) the consummation of a change of control or (ii) the date that is one day prior to the date of the Issuer's 2020 Annual Meeting of Stockholders (the earlier to occur of (i) or (ii), the "Vesting Date"), provided that Christopher Shackelton ("Shackelton") remains in the continuous service as a member of the board of directors of the Issuer at all times following the grant date (June 3, 2019) and prior to the Vesting Date.

F3 · ownership.nature: The Cash-Settled RSUs were granted on June 3, 2019 under the Issuer's 2018 Equity Incentive Plan. These securities were received by Shackelton in connection with his service as a member of the board of directors of the Issuer. Shackelton has agreed that all equity awards he receives for serving as a director of the Issuer shall be issued to Coliseum Capital Partners, L.P. ("CCP"). CCP is an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser.

F4 · ownership.nature: Shackelton and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC, and may be deemed to have an indirect pecuniary interest in the shares held by CCP, Coliseum Capital Partners II, L.P. ("CCP2" and, together with CCP, the "Funds") and a separate account investment advisory client of CCM (the "Separate Account") due to CCM's right to receive performance-related fees from the Separate Account and CC's right to receive performance-related fees from the Funds. Each of Shackelton, Gray, CCP, CCP2, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.

F5 · ownership.nature: Following the transaction reported herein, CCP, CCP2 and the Separate Account directly owned 1,167,330; 260,942; and 460,719 shares of Common Stock, respectively.

SEC source: 0001127602-19-020918 · form4.xml · derivative · entry 1

GOLDSTEIN MICHAEL · CIK 0001043027 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,905

Underlying: Common Stock, $.0001 Par Value · 18,905 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date.

F2 · derivative.exercise_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date.

F2 · derivative.expiration_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date.

SEC source: 0001127602-19-020914 · form4.xml · derivative · entry 1

Pate R Carter · CIK 0001641406 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,363

Underlying: Common Stock, $.0001 Par Value · 27,363 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date.

F2 · derivative.exercise_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date.

F2 · derivative.expiration_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date.

SEC source: 0001127602-19-020908 · form4.xml · derivative · entry 1

GOLDING DAVID W · CIK 0001286630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,905

Underlying: Common Stock, $.0001 Par Value · 18,905 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date.

F2 · derivative.exercise_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date.

F2 · derivative.expiration_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date.

SEC source: 0001127602-19-020904 · form4.xml · derivative · entry 1

Bronfein Michael G · CIK 0001345949 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,905

Underlying: Common Stock, $.0001 Par Value · 18,905 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Cash-Settled Restricted Stock Unit ("Cash-Settled RSU") is the economic equivalent of one share of BioScrip common stock. Upon vesting, each Cash-Settled RSU will entitle the awardee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2018 Equity Incentive Plan (the "Plan")) of one share of BioScrip common stock on the vesting date.

F2 · derivative.exercise_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date.

F2 · derivative.expiration_date: The Cash-Settled RSUs vest and become non-forfeitable on the earlier of (1) the consummation of a Change of Control (as defined in the Plan), and (2) the day before the Company's 2020 Annual Meeting, provided the awardee has remained in continuous service as a member of the Company's Board of Directors through such date.

SEC source: 0001127602-19-019233 · form4.xml · derivative · entry 3

Deitsch Stephen · CIK 0001704288 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.0001 Par Value · 56,263 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F1 · date: 56,263 RSUs vested on the first anniversary of the original grant date (May 3, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until May 16, 2019.

F4 · derivative.exercise_date: The Restricted Stock Units vest on the first anniversary of the date of grant.

F4 · derivative.expiration_date: The Restricted Stock Units vest on the first anniversary of the date of grant.

SEC source: 0001127602-19-019233 · form4.xml · nonDerivative · entry 2

Deitsch Stephen · CIK 0001704288 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,848

F3 · price: This transaction represents shares withheld by the Company for tax withholding on Mr. Deitsch's settlement of the RSU award described in this Form 4 that was settled on May 16, 2019.

SEC source: 0001127602-19-019233 · form4.xml · nonDerivative · entry 1

Deitsch Stephen · CIK 0001704288 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,154

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: 56,263 RSUs vested on the first anniversary of the original grant date (May 3, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until May 16, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001127602-19-019235 · form4.xml · derivative · entry 3

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.0001 Par Value · 197,727 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F1 · date: 197,727 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (May 3, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 197,727 RSUs until May 16, 2019.

F4 · derivative.exercise_date: The Restricted Stock Units vest on the first anniversary of the date of grant.

F4 · derivative.expiration_date: The Restricted Stock Units vest on the first anniversary of the date of grant.

SEC source: 0001127602-19-019235 · form4.xml · nonDerivative · entry 2

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,305

F3 · price: This transaction represents shares withheld by the Company for tax withholding on Mr. Greenleaf's settlement of the RSU award described in this Form 4 that was settled on May 16, 2019.

SEC source: 0001127602-19-019235 · form4.xml · nonDerivative · entry 1

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 438,039

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: 197,727 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (May 3, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 197,727 RSUs until May 16, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001127602-19-015956 · form4.xml · derivative · entry 5

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,850

Underlying: Common Stock, $.0001 Par Value · 98,425 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F3 · date: One third (98,425 RSUs) of Mr. Greenleaf's original award of 295,275 RSUs vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 98,425 RSUs until April 18, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F7 · derivative.exercise_date: The remaining 196,850 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/2018).

F7 · derivative.expiration_date: The remaining 196,850 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/2018).

SEC source: 0001127602-19-015956 · form4.xml · derivative · entry 4

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.0001 Par Value · 136,185 shares

Expires 2019-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F1 · date: 136,185 Restricted Stock Units (RSUs) vested in January 2019 based on the satisfaction of certain Company stock price trading targets; however, as provided in the grant agreement, the Company deferred settlement of the 136,185 RSUs until April 18, 2019

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F6 · balance_after: Depending on Company stock price at the end of the performance period, payout may be 0, 50, 100 or 200% of reported amount.

SEC source: 0001127602-19-015956 · form4.xml · nonDerivative · entry 3

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,312

F4 · price: This transaction represents shares withheld by the Company for tax withholding on Mr. Greenleaf's settlement of the two RSU awards described in this Form 4 that were settled on April 18, 2019.

SEC source: 0001127602-19-015956 · form4.xml · nonDerivative · entry 2

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,306

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · date: One third (98,425 RSUs) of Mr. Greenleaf's original award of 295,275 RSUs vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 98,425 RSUs until April 18, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001127602-19-015956 · form4.xml · nonDerivative · entry 1

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: 136,185 Restricted Stock Units (RSUs) vested in January 2019 based on the satisfaction of certain Company stock price trading targets; however, as provided in the grant agreement, the Company deferred settlement of the 136,185 RSUs until April 18, 2019

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001127602-19-016025 · form4.xml · derivative · entry 5

Deitsch Stephen · CIK 0001704288 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,370

Underlying: Common Stock, $.0001 Par Value · 19,685 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F3 · date: 19,685 RSUs vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until April 18, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F7 · derivative.exercise_date: The remaining 39,370 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/2018).

F7 · derivative.expiration_date: The remaining 39,370 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/2018).

SEC source: 0001127602-19-016025 · form4.xml · derivative · entry 4

Deitsch Stephen · CIK 0001704288 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.0001 Par Value · 66,902 shares

Expires 2019-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F1 · date: 66,902 Restricted Stock Units (RSUs) vested in January 2019 based on the satisfaction of certain Company stock price trading targets; however, as provided in the grant agreement, the Company deferred settlement of the 66,902 RSUs until April 18, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F6 · balance_after: Depending on Company stock price at the end of the performance period, payout may be 0%, 50%, 100% or 150% of reported amount.

SEC source: 0001127602-19-016025 · form4.xml · nonDerivative · entry 3

Deitsch Stephen · CIK 0001704288 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,891

F4 · price: This transaction represents shares withheld by the Company for tax withholding on Mr. Deitsch's settlement of the two RSU awards described in this Form 4 that were settled on April 18, 2019.

SEC source: 0001127602-19-016025 · form4.xml · nonDerivative · entry 2

Deitsch Stephen · CIK 0001704288 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,985

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · date: 19,685 RSUs vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until April 18, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001127602-19-016025 · form4.xml · nonDerivative · entry 1

Deitsch Stephen · CIK 0001704288 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: 66,902 Restricted Stock Units (RSUs) vested in January 2019 based on the satisfaction of certain Company stock price trading targets; however, as provided in the grant agreement, the Company deferred settlement of the 66,902 RSUs until April 18, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001127602-19-015860 · form4.xml · derivative · entry 5

Booker Harriet · CIK 0001723978 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,419

Underlying: Common Stock, $.0001 Par Value · 20,210 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F3 · date: One third (20,210 RSUs) of Ms. Bookers original award of 60,629 RSUs vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 20,210 RSUs until April 17, 2019.

F7 · derivative.exercise_date: The remaining 40,419 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/18).

F7 · derivative.expiration_date: The remaining 40,419 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/18).

SEC source: 0001127602-19-015860 · form4.xml · derivative · entry 4

Booker Harriet · CIK 0001723978 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.0001 Par Value · 13,417 shares

Expires 2019-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F1 · date: 13,417 Restricted Stock Units (RSUs) vested in January 2019 based on the satisfaction of certain Company stock price trading targets; however, as provided in the grant agreement, the Company deferred settlement of the 13,417 RSUs until April 17, 2019.

F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.

F6 · balance_after: Depending on Company stock price at the end of the performance period, payout may be 0, 50, 100 or 150% of reported amount.

SEC source: 0001127602-19-015860 · form4.xml · nonDerivative · entry 3

Booker Harriet · CIK 0001723978 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,490

F4 · price: This transaction represents shares withheld by the Company for tax withholding on Ms. Booker's settlement of the two RSU awards described in this Form 4 that were settled on April 17, 2019.

SEC source: 0001127602-19-015860 · form4.xml · nonDerivative · entry 2

Booker Harriet · CIK 0001723978 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,627

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · date: One third (20,210 RSUs) of Ms. Bookers original award of 60,629 RSUs vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 20,210 RSUs until April 17, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001127602-19-015860 · form4.xml · nonDerivative · entry 1

Booker Harriet · CIK 0001723978 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: 13,417 Restricted Stock Units (RSUs) vested in January 2019 based on the satisfaction of certain Company stock price trading targets; however, as provided in the grant agreement, the Company deferred settlement of the 13,417 RSUs until April 17, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001127602-19-015842 · form4.xml · derivative · entry 3

Stalmack Kathryn · CIK 0001749052 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,684

Underlying: Common Stock, $.0001 Par Value · 9,843 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F1 · date: One third (9,843 Restricted Stock Unites (RSUs)) vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until April 17, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The remaining 19,684 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/2018).

F4 · derivative.expiration_date: The remaining 19,684 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/2018).

SEC source: 0001127602-19-015842 · form4.xml · nonDerivative · entry 2

Stalmack Kathryn · CIK 0001749052 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,975

F3 · price: This transaction represents shares withheld by the Company for tax withholding on Ms. Stalmack's settlement of the 9,843 RSUs that vested on April 11, 2019.

SEC source: 0001127602-19-015842 · form4.xml · nonDerivative · entry 1

Stalmack Kathryn · CIK 0001749052 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,353

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: One third (9,843 Restricted Stock Unites (RSUs)) vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until April 17, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001127602-19-015310 · form4.xml · derivative · entry 3

Kepler Jody · CIK 0001693167 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.0001 Par Value · 23,454 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one share of Common Stock

F1 · date: 23,454 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (April 5, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until April 10, 2019.

F2 · price: Each Restricted Stock Unit represents the right to receive one share of Common Stock

F4 · derivative.exercise_date: The Restricted Stock Units vest in their entirety on the first anniversary of the date of grant.

F4 · derivative.expiration_date: The Restricted Stock Units vest in their entirety on the first anniversary of the date of grant.

SEC source: 0001127602-19-015310 · form4.xml · nonDerivative · entry 2

Kepler Jody · CIK 0001693167 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,411

F3 · price: This transaction represents shares withheld by the Company for tax withholding on Ms. Kepler's settlement of the 23,454 RSUs that vested on April 5, 2019

SEC source: 0001127602-19-015310 · form4.xml · nonDerivative · entry 1

Kepler Jody · CIK 0001693167 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,454

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: 23,454 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (April 5, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until April 10, 2019.

F2 · price: Each Restricted Stock Unit represents the right to receive one share of Common Stock

SEC source: 0001127602-19-015308 · form4.xml · derivative · entry 3

Stalmack Kathryn · CIK 0001749052 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.0001 Par Value · 73,745 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F1 · date: 73,745 Restricted Stock Unites (RSUs) vested on the first anniversary of the original grant date (April 5, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until April 10, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units vest in their entirety on the on the first anniversary of the date of grant.

F4 · derivative.expiration_date: The Restricted Stock Units vest in their entirety on the on the first anniversary of the date of grant.

SEC source: 0001127602-19-015308 · form4.xml · nonDerivative · entry 2

Stalmack Kathryn · CIK 0001749052 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,510

F3 · price: This transaction represents shares withheld by the Company for tax withholding on Ms. Stalmack's settlement of the 73,745 RSUs that vested on April 5, 2019.

SEC source: 0001127602-19-015308 · form4.xml · nonDerivative · entry 1

Stalmack Kathryn · CIK 0001749052 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,745

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: 73,745 Restricted Stock Unites (RSUs) vested on the first anniversary of the original grant date (April 5, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until April 10, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

SEC source: 0001127602-19-027082 · form4.xml · nonDerivative · entry 1

DENNESS RICHARD · CIK 0001746409 · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,727

F1 · price: The shares of Common Stock reported on this Form 4 were originally granted as restricted stock units on March 13, 2019, however no Form 4 was filed at that time. Such restricted stock units vested on August 1, 2019.

SEC source: 0001127602-19-005479 · form4.xml · derivative · entry 3

GREENLEAF DANIEL E · CIK 0001208492 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,700

Underlying: Common Stock, $.0001 Par Value · 64,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F1 · date: One third (64,350 RSUs) of Mr. Greenleaf's original award of 193,050 RSUs vested on the first anniversary of the original grant date (November 27, 2017); however, as provided in the grant agreement, the Company deferred settlement of the 64,350 RSUs until February 8, 2019.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F4 · derivative.exercise_date: The remaining 128,700 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (11/28/2017).

F4 · derivative.expiration_date: The remaining 128,700 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (11/28/2017).